Detalhe da pesquisa
1.
A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program.
Br J Cancer
; 129(5): 852-860, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37468569
2.
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.
Cell Rep
; 24(3): 630-641, 2018 07 17.
Artigo
Inglês
| MEDLINE | ID: mdl-30021161
3.
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem.
Eur J Gastroenterol Hepatol
; 29(1): 48-55, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27623000